Corona Remedies P/B Ratio
Corona Remedies P/B ratio. Corona Remedies (CORONA) P/B ratio is 17.01 (High), book value per share ₹122.46 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Corona Remedies share price today.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
CORONA P/B Ratio — Valuation Insights & Book Value Analysis
Corona Remedies price-to-book ratio interpretation, valuation status and historical context — current P/B 17.01 (High). View CORONA 52-week performance for the annual high/low range and current price position.
- Stock appears overvalued with PB of 17.01, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of 0.01
Corona Remedies P/B Ratio Historical Trend
CORONA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse Corona Remedies ownership pattern to track promoter, FII and institutional holdings.
CORONA Historical P/B Ratio — Book Value Per Share & Year-End Price
Corona Remedies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 16.61 | ₹122.46 | ₹2034.20 | ₹747 | High |
| 2025 | 13.94 | ₹99.34 | ₹1384.90 | ₹606 | High |
CORONA vs Healthcare Peers — P/B Ratio Comparison
Corona Remedies P/B 17.01 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |